Autolus Therapeutics (NASDAQ:AUTL) Announces Quarterly Earnings Results, Meets Estimates

Résumé détaillé

Autolus Therapeutics (NASDAQ:AUTL - Get Free Report) posted its earnings results on Tuesday. The company reported ($0.21) EPS for the quarter, meeting analysts' consensus estimates of ($0.21). Autolus Therapeutics had a negative net margin of 238.66% and a negative return on equity of 178.66%. The business had revenue of $41.24 million for the quarter, compared to the consensus estimate of $39.54 million.